What is The Oncology Institute, Inc.'s D&A?

The Oncology Institute, Inc. (TOI) reported D&A of $1.62M in Q1 2026.

How has The Oncology Institute, Inc.'s D&A changed year-over-year?

The Oncology Institute, Inc.'s D&A decreased by 9.4% year-over-year, from $1.78M to $1.62M.

What is the long-term trend for The Oncology Institute, Inc.'s D&A?

Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s D&A has grown at a 20.1% compound annual growth rate (CAGR), from $3.34M to $6.94M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

The Oncology Institute, Inc. TOI D&A

D&A at other companies

McKessonMCK

$65M+12.1%

Evolent Health, Inc.EVH

$21.56M-10.4%

ImmunomeIMNM

$603K-1.3%

Option Care Health, Inc.OPCH

$15.66M-4.4%

Summit TherapeuticsSMMT

$44K+76.0%

BrightSpring Health Services, Inc.BTSG

$39.09M-7.3%

Segments

By segment

See full

Patient services$737K-2.4%

Specialty pharmacy$3K—

Clinical trials & other$0-100%

Other financials

Income statement

See full

Revenue$147.4M+41.2%

Operating income-$6.5M+34.3%

Net income-$2.5M+87.3%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$30.3M-23.8%

Total debt$104.9M+2.5%

Total equity-$16.3M-421%

Total assets$168.2M+2.6%

Cash flow

See full

Operating cash flow-$2.2M+55.6%

CapEx$1.0M+218%

Free cash flow-$3.3M+38.7%

Valuation

See full

Market cap$511.91M+133%

Enterprise value$586.58M+108%

P/S0.9×+0.4×

Profitability

See full

Operating margin-6%-2.1pp

Net margin-8%-2.7pp

FCF margin-5.1%—

Returns & leverage

See full

Return on equity-277.6%-700pp

Debt / equity20.2×+17.3×

Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Oncology Institute, Inc.'s D&A?: The Oncology Institute, Inc. (TOI) reported D&A of $1.62M in Q1 2026.
How has The Oncology Institute, Inc.'s D&A changed year-over-year?: The Oncology Institute, Inc.'s D&A decreased by 9.4% year-over-year, from $1.78M to $1.62M.
What is the long-term trend for The Oncology Institute, Inc.'s D&A?: Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s D&A has grown at a 20.1% compound annual growth rate (CAGR), from $3.34M to $6.94M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.